There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to recent findings by rare cancer researcher Dr. Taran Gujral, head of Fred Hutch's ...

The ambiguity in medical imaging can present major challenges for clinicians who are trying to identify disease. For instance ...